GC Genome Corporation (KOSDAQ:340450)
South Korea
· Delayed Price · Currency is KRW
7,700.00
+70.00 (0.92%)
At close: Dec 5, 2025
GC Genome Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Debt / Equity Ratio | 0.06 | 0.14 | 0.47 | 0.40 | 0.74 | 0.66 | |
| Debt / EBITDA Ratio | 1.03 | 2.35 | 3.18 | - | - | 12.64 | |
| Debt / FCF Ratio | 10.28 | 94.54 | - | - | - | - | |
| Asset Turnover | - | 0.62 | 0.60 | 0.53 | 0.44 | 0.49 | |
| Inventory Turnover | - | 11.96 | 11.56 | 14.85 | - | - | |
| Quick Ratio | 8.16 | 3.74 | 1.00 | 2.13 | 6.26 | 12.49 | |
| Current Ratio | 8.57 | 4.27 | 1.12 | 2.32 | 6.42 | 12.64 | |
| Return on Equity (ROE) | - | -4.32% | -2.13% | -16.52% | 1.56% | -0.02% | |
| Return on Assets (ROA) | - | -1.85% | 0.22% | -4.43% | -3.13% | -0.01% | |
| Return on Capital (ROIC) | - | -2.07% | 0.27% | -5.76% | -4.11% | -0.01% | |
| Return on Capital Employed (ROCE) | 1.40% | -3.30% | 0.50% | -8.40% | -5.60% | 0.00% | |
| Buyback Yield / Dilution | -12.46% | 0.66% | -13.53% | -0.97% | 10.25% | -90.88% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.